ABBOTT LABORATORIES — Director's Dealing 2024

Jan 31, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2024-01-29

Reporting Person: Wainer Andrea F (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-01-29	Common shares without par value	M	25000	$44.40	Acquired	90027	Direct
2024-01-29	Common shares without par value	S	25000	$112.50	Disposed	65027	Direct
2024-01-29	Common shares without par value	M	17500	$59.94	Acquired	82527	Direct
2024-01-29	Common shares without par value	S	17500	$112.50	Disposed	65027	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-29	Option (right to buy)	$44.40	M	25000	Disposed	2027-02-16	Common Shares (25000)	Direct
2024-01-29	Option (right to buy)	$59.94	M	17500	Disposed	2028-02-15	Common Shares (17500)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

F2: Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.